Clinical Trial Update: Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol) [NA]

View source ↗

Summary

This clinical trial investigates intestinal permeability in patients with liver cirrhosis before and after treatment with the non-selective beta blocker propran…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: Liver Cirrhoses | NA | Status: UNKNOWN